Social anxiety disorder or SAD affects approximately 7% of the United States population annually. It is twice as common among females and the average age of onset is 13 years.…
![Social Anxiety Disorder and CBD](https://www.drjimcollins.com/wp-content/uploads/2023/11/2024-01-15-Social-Anxiety-Disorder-and-CBD-1200x508.jpg)
Social anxiety disorder or SAD affects approximately 7% of the United States population annually. It is twice as common among females and the average age of onset is 13 years.…
Alzheimer’s disease is an incurable, irreversible, and progressive neurodegenerative disorder that accounts for between 60-80% of dementia cases around the world. In the United States, 13.8 million people will develop…
CBD is one of the most researched cannabinoids for its many physical and mental health benefits. Recently there has been a focus on the possible use of CBD as an…
Cannabidiol or CBD has been proposed as a treatment for a variety of neuropsychiatric conditions including depression and bipolar disorder, schizophrenia and other psychotic disorders and anxiety. It appears to…
Understanding the complex pathophysiology of Alzheimer’s disease is greatly needed in order to develop enhanced treatments that will improve symptoms and quality of life. Recently, the gut has received attention…
Although CBD (cannabidiol) has taken center stage in the medical hemp and cannabis world, there are other important molecules that are gaining the attention of researchers and consumers alike. They…